These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 32494201)

  • 1. Predictive Factors for Level V Lymph Node Metastases in Papillary Thyroid Carcinoma with
    Li GY; Tan HL; Chen P; Hu HY; Liu M; Ou-Yang DJ; Khushbu RA; Pun D; Li JD; Zhang ZP; Yang Q; Huang P; Chang S
    Cancer Manag Res; 2020; 12():3371-3378. PubMed ID: 32494201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrating BRAF
    Zhang Z; Zhang X; Yin Y; Zhao S; Wang K; Shang M; Chen B; Wu X
    BMC Cancer; 2022 Apr; 22(1):461. PubMed ID: 35473554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prediction model incorporating the BRAF
    Liu S; Liu C; Zhao L; Wang K; Li S; Tian Y; Jiao B; Gui Z; Yu T; Zhang L
    Eur J Surg Oncol; 2021 Nov; 47(11):2774-2780. PubMed ID: 34483032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for level V lymph node metastases in solitary papillary thyroid carcinoma with clinically lateral lymph node metastases.
    Yang J; Gong Y; Yan S; Zhu J; Li Z; Gong R
    Cancer Med; 2016 Aug; 5(8):2161-8. PubMed ID: 27368106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pattern of and clinicopathologic risk factors for lateral lymph node metastases in papillary thyroid carcinoma patients with lateral cervical lymphadenopathy.
    Gong Y; Yang J; Yan S; Su A; Liu F; Gong R; Zhu J; Li Z
    Medicine (Baltimore); 2018 Sep; 97(36):e12263. PubMed ID: 30200164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting factors of central lymph node metastasis and BRAF
    Zhou SL; Guo YP; Zhang L; Deng T; Xu ZG; Ding C; Sun WC; Zhao YW; Kong LF
    World J Surg Oncol; 2021 Jul; 19(1):211. PubMed ID: 34256769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for central lymph node metastasis in patients with papillary thyroid carcinoma: a retrospective study.
    Du J; Yang Q; Sun Y; Shi P; Xu H; Chen X; Dong T; Shi W; Wang Y; Song Z; Shang X; Tian X
    Front Endocrinol (Lausanne); 2023; 14():1288527. PubMed ID: 38047112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The synergic effect of BRAF
    Qu HJ; Qu XY; Hu Z; Lin Y; Wang JR; Zheng CF; Tan Z
    Endocr J; 2018 Jan; 65(1):113-120. PubMed ID: 29070763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive factors for central lymph node and lateral cervical lymph node metastases in papillary thyroid carcinoma.
    Feng JW; Yang XH; Wu BQ; Sun DL; Jiang Y; Qu Z
    Clin Transl Oncol; 2019 Nov; 21(11):1482-1491. PubMed ID: 30879178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive Value of BRAF
    Song JY; Sun SR; Dong F; Huang T; Wu B; Zhou J
    Curr Med Sci; 2018 Oct; 38(5):785-797. PubMed ID: 30341513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BRAF
    Dong SY; Zeng RC; Jin LP; Yang F; Zhang XJ; Yao ZH; Zhang XH; Wang OC
    Oncol Lett; 2017 Oct; 14(4):4122-4134. PubMed ID: 28943919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk Factors for Neck Nodal Metastasis in Papillary Thyroid Cancer With BRAF V600E Mutation.
    Han Y; Hou L; Zhao B; Gao L; Li S
    Front Endocrinol (Lausanne); 2022; 13():884428. PubMed ID: 35784548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conventional Ultrasound, Immunohistochemical Factors and BRAF
    Chen J; Li XL; Zhao CK; Wang D; Wang Q; Li MX; Wei Q; Ji G; Xu HX
    Ultrasound Med Biol; 2018 Nov; 44(11):2296-2306. PubMed ID: 30100099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum TSH levels are associated with postoperative recurrence and lymph node metastasis of papillary thyroid carcinoma.
    Xiang Y; Xu Y; Bhandari A; Sindan N; Hirachan S; Yang Q; Guo G; Shen Y
    Am J Transl Res; 2021; 13(6):6108-6116. PubMed ID: 34306349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BRAF
    Shi C; Cao J; Shi T; Liang M; Ding C; Lv Y; Zhang W; Li C; Gao W; Wu G; Man J
    World J Surg Oncol; 2020 Jun; 18(1):145. PubMed ID: 32593310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BRAF V600E and lymph node metastases in papillary thyroid cancer.
    Chen P; Pan L; Huang W; Feng H; Ouyang W; Wu J; Wang J; Deng Y; Luo J; Chen Y
    Endocr Connect; 2020 Oct; 9(10):999-1008. PubMed ID: 33064665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Online Model for Central Lymph Node Metastases in Papillary Thyroid Carcinoma With BRAF V600E Mutation.
    Chen H; Pan WK; Ren SY; Zhou YL
    Am J Clin Oncol; 2024 Aug; 47(8):383-390. PubMed ID: 38664891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive factors of lateral lymph node metastasis in conventional papillary thyroid carcinoma.
    Song M; Huang Z; Wang S; Huang J; Shi H; Liu Y; Huang Y; Yin Y; Wu Z
    Gland Surg; 2020 Aug; 9(4):1000-1007. PubMed ID: 32953608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive evaluation of risk factors for lymph node metastasis in patients with papillary thyroid carcinoma.
    Dong Y; Wang D; Luo Y; Chen L; Bai H; Shen Y; Zhang Y; Chen X; Su X; Zhao J; Liu H; Lu J; Yao Z; Zhao Y; He C; Li X
    Oncol Lett; 2021 Mar; 21(3):188. PubMed ID: 33574927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BRAF
    Kurtulmus N; Ertas B; Saglican Y; Kaya H; Ince U; Duren M
    Eur Thyroid J; 2016 Sep; 5(3):195-200. PubMed ID: 27843810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.